• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Marker Therapeutics, Inc.

Marker Therapeutics, Inc.

Public
MRKR
United States
SectorHealthcare
CountryUnited States
Market cap26.68M
A clinical-stage immuno-oncology company developing T cell-based immunotherapies for cancer and hematologic diseases.

Where to buy Marker Therapeutics, Inc. (MRKR)

MRKR trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare